These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29486262)

  • 1. Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
    Elamin KM; Motoyama K; Higashi T; Yamashita Y; Tokuda A; Arima H
    Int J Biol Macromol; 2018 Jul; 113():386-394. PubMed ID: 29486262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supramolecular Complex of Methyl-β-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent.
    Elamin KM; Yamashita Y; Higashi T; Motoyama K; Arima H
    Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):277-285. PubMed ID: 29269686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
    Kameyama K; Motoyama K; Tanaka N; Yamashita Y; Higashi T; Arima H
    Int J Nanomedicine; 2017; 12():3433-3446. PubMed ID: 28496320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma.
    Motoyama K; Onodera R; Tanaka N; Kameyama K; Higashi T; Kariya R; Okada S; Arima H
    Biol Pharm Bull; 2015; 38(3):374-9. PubMed ID: 25757918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
    Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
    Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of autophagy in antitumor activity of folate-appended methyl-β-cyclodextrin.
    Onodera R; Motoyama K; Tanaka N; Ohyama A; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
    Sci Rep; 2014 Mar; 4():4417. PubMed ID: 24646866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of the complex of doxorubicin with folate-conjugated methyl-β-cyclodextrin for tumor-selective cancer chemotherapy.
    Motoyama K; Onodera R; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
    J Drug Target; 2014 Oct; 22(3):211-219. PubMed ID: 24219311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of Cyclodextrin-based Cancer Treatment].
    Motoyama K
    Yakugaku Zasshi; 2015; 135(11):1291-8. PubMed ID: 26521878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of folate-appended methyl-β-cyclodextrin as an anticancer agent.
    Onodera R; Motoyama K; Okamatsu A; Higashi T; Arima H
    Sci Rep; 2013; 3():1104. PubMed ID: 23346361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
    Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
    Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-Appended Hydroxypropyl-β-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid Leukemia Cells.
    Kubota Y; Hoshiko T; Higashi T; Motoyama K; Okada S; Kimura S
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
    Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
    Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
    Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
    Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
    Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
    J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles of folic acid-methyl-β-cyclodextrin (FA-MβCD)/adamantane-albumin exhibit enhanced antitumor activity compared with FA-MβCD alone.
    Sakai A; Yamashita Y; Misumi S; Kishimoto N; Onodera R; Higashi T; Arima H; Motoyama K
    FEBS Open Bio; 2023 Feb; 13(2):233-245. PubMed ID: 36537756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
    Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
    Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
    Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic Acid-Appended Hydroxypropyl-β-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death.
    Hoshiko T; Kubota Y; Onodera R; Higashi T; Yokoo M; Motoyama K; Kimura S
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
    Yin JJ; Sharma S; Shumyak SP; Wang ZX; Zhou ZW; Zhang Y; Guo P; Li CZ; Kanwar JR; Yang T; Mohapatra SS; Liu W; Duan W; Wang JC; Li Q; Zhang X; Tan J; Jia L; Liang J; Wei MQ; Li X; Zhou SF
    PLoS One; 2013; 8(5):e62289. PubMed ID: 23658721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.